Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank86
3Y CAGR+64.0%
5Y CAGR+161.8%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+64.0%/yr
vs -32.5%/yr prior
5Y CAGR
+161.8%/yr
Recent deceleration
Acceleration
+96.5pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
123x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $158.96M | +6212.9% |
| 2024 | $2.52M | -96.0% |
| 2023 | $63.66M | +76.8% |
| 2022 | $36.01M | -50.1% |
| 2021 | $72.20M | +5488.6% |
| 2020 | $1.29M | -99.8% |
| 2019 | $796.64M | +359.6% |
| 2018 | $173.33M | +202.9% |
| 2017 | $57.23M | +619.0% |
| 2016 | $7.96M | - |